Missouri GOP Attorney General Andrew Bailey has launched an investigation into a network of clinics across the state that he says are encouraging minors to transition from one gender to another. The investigation began last month following allegations of child transitioning going too far at the Pediatric Transgender Center at St. Louis Children’s Hospital.
A whistleblower voluntarily working at the center claimed that the procedures were harming children and that there were no adequate safety measures in place. The attorney general is investigating whether these clinics are using experimental drugs on children without parental consent, which is illegal. Bailey describes the use of puberty blockers and hormones as damaging and irreversible and not approved by the FDA for such procedures.
— Common sense woman 🇺🇸✝️ (@GramsH18) March 23, 2023
Bailey has now confirmed that his office has launched a multi-agency investigation into the Pediatric Transgender Center at St. Louis Children’s Hospital. His office has received an affidavit from the whistleblower and documents that support her allegations. The Missouri Department of Social Services and the Division of Professional Registration are also involved in the investigation. Bailey has said that individuals at the center have been harming hundreds of children yearly by using experimental drugs.
He stresses that the focus of the investigation is to ensure that children are not harmed by individuals who may be more concerned with a radical social agenda than children’s health.
Bailey’s investigation and the whistleblower’s allegations highlight the potential risks associated with using experimental drugs on children. Critics of gender transitioning argue that such interventions are not fully understood and significant concerns about their long-term effects exist. The investigation has sparked controversy, with some accusing Bailey of targeting transgender individuals and infringing on their rights. However, Bailey maintains that his investigation is motivated by a desire to protect children from harm and that using experimental drugs without parental consent is illegal.
Even as Americans are expressing outrage at using puberty blockers and hormone treatments on children, the controversial procedures are recognized treatments for gender dysphoria by major medical organizations such as the American Academy of Pediatrics and the World Professional Association for Transgender Health. However, there are concerns about the overuse of these treatments and the lack of proper oversight in some clinics.
The following clip shows the progressive slant being given the story by the local corporate media in Missouri:
Bailey’s investigation raises essential questions about the regulation of gender transitioning procedures and the use of experimental drugs on children. While it is important to respect the rights of individuals to make choices about their gender identity, it is also essential to ensure that these choices are made with adequate information and support by persons with the maturity and capacity to decide their permanent medical future.
The Missouri investigation may help to shed light on potential problems in the system and lead to improvements in the regulation of gender transitioning procedures around the nation.